The document follows two earlier consensus documents, released in 2013 and 2016. Dominick Angiolillo, MD, PhD (University of Florida College of Medicine – Jacksonville), senior author of the paper, ...
Please provide your email address to receive an email when new articles are posted on . New data from the HI-TECH study presented at EuroPCR indicate that ticagrelor did not improve endothelial ...
Using genetic tests to guide the prescribing of post-PCI P2Y12 inhibitors can reduce ischemic events in patients with coronary artery disease, according to results of a new meta-analysis. Its authors ...
Dual antiplatelet therapy with aspirin and a P2Y12 inhibitor, such as clopidogrel, is indicated for up to 1 year in patients with ACS and those undergoing PCI with stent implantation. Approximately 20 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback